Cargando…
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
Triple-negative breast cancer (TNBC) is a subgroup of 15%-20% of diagnosed breast cancer patients. It is generally considered to be the most difficult breast cancer subtype to deal with, due to the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor...
Autores principales: | Giuli, M. V., Giuliani, E., Screpanti, I., Bellavia, D., Checquolo, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657611/ https://www.ncbi.nlm.nih.gov/pubmed/31379945 http://dx.doi.org/10.1155/2019/8707053 |
Ejemplares similares
-
Notch signaling in female cancers: a multifaceted node to overcome drug resistance
por: Giuli, Maria V., et al.
Publicado: (2021) -
Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer
por: Pelullo, Maria, et al.
Publicado: (2019) -
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
por: Diluvio, Giulia, et al.
Publicado: (2018) -
Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
por: Ceccarelli, Simona, et al.
Publicado: (2019) -
Notch3/Jagged1 Circuitry Reinforces Notch Signaling and Sustains T-ALL()()
por: Pelullo, Maria, et al.
Publicado: (2014)